TH96078B - Benzodiazepine salts and their crystallinity - Google Patents

Benzodiazepine salts and their crystallinity

Info

Publication number
TH96078B
TH96078B TH701002507A TH0701002507A TH96078B TH 96078 B TH96078 B TH 96078B TH 701002507 A TH701002507 A TH 701002507A TH 0701002507 A TH0701002507 A TH 0701002507A TH 96078 B TH96078 B TH 96078B
Authority
TH
Thailand
Prior art keywords
phenyl
fluoro
crystallinity
benzo
dihydro
Prior art date
Application number
TH701002507A
Other languages
Thai (th)
Other versions
TH96078A (en
Inventor
นาย ซิงลองเจียง นาย ไพออทเอช. คาร์พินสกี้ น.ส. ลิลลี่เฟ็ง
Original Assignee
โนวาร์ทิส เอจี โนวาร์ทิส เอจี
Filing date
Publication date
Application filed by โนวาร์ทิส เอจี โนวาร์ทิส เอจี filed Critical โนวาร์ทิส เอจี โนวาร์ทิส เอจี
Publication of TH96078B publication Critical patent/TH96078B/en
Publication of TH96078A publication Critical patent/TH96078A/en

Links

Abstract

การประดิษฐ์นี้เกี่ยวข้องกับ สารเกลือของ 1-(2-ฟลูออโร-ฟีนิล)-3-(2-ออกโซ-5-ฟีนิล- 2,3-ไดไฮโดร-1H-เบนโซ[e][1,4]ไดอะเซพิน-3-อิล)-ยูเรีย และรูปแบบที่เป็นผลึกของมัน, กระบวนการผลิตและการใช้ประโยชน์ของมัน และการเตรียมสารทางเภสัชกรรมที่ประกอบด้วย สารเกลือดังกล่าว และรูปแบบที่เป็นผลึกของมันด้วย This invention involves salts of 1- (2-fluoro-phenyl) -3- (2-oxo-5-phenyl-2,3-dihydro-1H-benzo [e]. [1,4] diazepin-3-il) - urea And its crystalline form, its manufacturing process and its uses And pharmaceutical preparations containing Such substances And its crystal form too

Claims (4)

1. สารเกลือของ 1-(2-ฟลูออโร-ฟีนิล)-3-(2-ออกโซ-5-ฟีนิล-2,3-ไดไฮโดร-1H-เบนโซ [e][1,4]ไดอะเซพิน-3-อิล)-ยูเรีย ด้วยกรดเบนซีนซัลโฟนิก1. Salts of 1- (2-fluoro-phenyl) -3- (2-oxo-5-phenyl-2,3-dihydro-1H-benzo [e] [1,4] diazepin-3-il) - urea With benzene sulfonic acid 2. สารเกลือของ 1-(2-ฟลูออโร-ฟีนิล)-3-(2-ออกโซ-5-ฟีนิล-2,3-ไดไฮโดร-1H-เบนโซ [e][1,4]ไดอะเซพิน-3-อิล)-ยูเรีย ด้วยกรดเบนซีนซัลโฟนิก ที่อยู่ในรูปแบบที่เป็นผลึก2. Salt substances of 1- (2-fluoro-phenyl) -3- (2-oxo-5-phenyl-2,3-dihydro-1H-benzo [e] [1,4] diazepin-3-il) - urea With benzene sulfonic acid In crystal form 3. 1-(2-ฟลูออโร-ฟีนิล)-3-(2-ออกโซ-5-ฟีนิล-2,3-ไดไฮโดร-1H-เบนโซ [e][1,4]ไดอะเซพิน-3-อิล)-ยูเรีย บีไซเลต โมโนไฮเดรท ที่เป็นผลึก3.1- (2- fluoro-phenyl) -3- (2-oxo-5-phenyl-2,3-dihydro-1H-benzo [e] [1,4] diacetin-3-il) - crystalline urea bcylate monohydrate. 4. 1-(2-ฟลูออโร-ฟ4. 1- (2- fluoro-phosphate
TH701002507A 2007-05-21 Benzodiazepine salts and their crystallinity TH96078A (en)

Publications (2)

Publication Number Publication Date
TH96078B true TH96078B (en) 2009-06-18
TH96078A TH96078A (en) 2009-06-18

Family

ID=

Similar Documents

Publication Publication Date Title
DE602006002624D1 (en) Crystalline beta of ivabradine hydrochloride, process for its preparation and pharmaceutical composition containing the same
ATE396974T1 (en) CRYSTAL INFORMATION GAMMA OF IVABRADINE HYDROCHLORIDE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
WO2009131974A8 (en) Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
DE602006001411D1 (en) Crystalline form gamma-d of ivabradine hydrochloride, process for its preparation and pharmaceutical composition containing the same
CR9505A (en) ANHYDING CRYSTAL FORMS OF THE N- (1- (2-ETOXIETIL) -5- (N-ETIL-N-METHYLAMINE) -7- (4-METHYLPIRIDIN-2-IL-AMINO) -1H-PIRAZOLO (4,3- D) PYRIMIDINE-3-CABONIL) METHANOSULPHONAMIDE
WO2007006307A3 (en) Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
BRPI0514537B8 (en) pyrazole substituted aminoeteroaryl compounds and pharmaceutical composition comprising them
CL2007002499A1 (en) SALES CITRATE AND TARTRATE OF COMPOUNDS DERIVED FROM PIRROLIDINILAMINOACETILPIRROLIDINBORONICO ACID, DPP-IV INHIBITORS; PREPARATION METHOD; SOLID FORM; PHARMACEUTICAL COMBINATION, USEFUL FOR THE TREATMENT OF DIABETES.
PT2134702T (en) 6- [2- (METHYLARBAMOYL) PHENYLSULPHANYL] -3-E- [2- (PYRIDIN-2-YL) ETENYL] INDAZOLE CRYSTALLINE FORM FOR THE TREATMENT OF FREQUENT CELL GROWTH IN MAMMALS
WO2011062766A3 (en) 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
WO2011062765A3 (en) 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
BRPI0414499A (en) crystalline form pharmaceutical composition, process for the manufacture of a pharmaceutical composition, use of a crystalline form, method of treating a disease condition, and process for the manufacture of a crystalline form
WO2009034029A3 (en) 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists
TH96078B (en) Benzodiazepine salts and their crystallinity
AR053586A1 (en) SALE PREPARATION PROCESS OF 4 - [[5 - [(CICLOPROPILAMINO) CARBONIL] -2-METHYLPENYL] AMINO] -5-METHYL-N- PROPILPIRROLO [2,1, F] [1,2,4] TRIAZIN-6 -CARBOXAMIDE AND STABLE CRYSTAL SHAPES OF SALES SALES
DE502006003194D1 (en) SALTS OF SUBSTITUTED ALLOPHANIC ACID ESTERS AND THEIR USE IN MEDICINAL PRODUCTS
WO2007065684A3 (en) Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents
NO20073758L (en) 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as CGRP antagonists
TH96078A (en) Benzodiazepine salts and their crystallinity
WO2006090268A3 (en) Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin
BRPI0509506A8 (en) CRYSTALLINE FORM OF PYRAZOLES, PROCESS FOR THE CONVERSION OF THE SAME, PHARMACEUTICAL COMPOSITION, USE, PROCESS FOR MAKING THE CRYSTALLINE FORM AND PROCESS FOR THE PRODUCTION OF SAID FORM
DE112006000999A5 (en) Formyltetrahydrophyrans, process for their preparation and their use in the preparation of liquid crystalline compounds
WO2007060342A3 (en) Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells
WO2008106479A3 (en) Poly(1,4-piperazin-2-ones) as rod-like protein- protein interaction inhibitors and their production
BRPI0818065A8 (en) CHEMOTHERAPEUTIC DERIVATIVE OF CRYSTALLINE INDAZOLE